These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 10572113

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Bleeding and surgery in children with Glanzmann thrombasthenia with and without the use of recombinant factor VII a.
    Hennewig U, Laws HJ, Eisert S, Göbel U.
    Klin Padiatr; 2005; 217(6):365-70. PubMed ID: 16307424
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The international, prospective Glanzmann Thrombasthenia Registry: treatment and outcomes in surgical intervention.
    Poon MC, d'Oiron R, Zotz RB, Bindslev N, Di Minno MN, Di Minno G, Glanzmann Thrombasthenia Registry Investigators.
    Haematologica; 2015 Aug; 100(8):1038-44. PubMed ID: 26001792
    [Abstract] [Full Text] [Related]

  • 8. Low Concentrations of Recombinant Factor VIIa May Improve the Impaired Thrombin Generation of Glanzmann Thrombasthenia Patients.
    Levy-Mendelovich S, Levy T, Budnik I, Barg AA, Rosenberg N, Seligsohn U, Kenet G, Livnat T.
    Thromb Haemost; 2019 Jan; 119(1):117-127. PubMed ID: 30597506
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Prophylactic and therapeutic recombinant factor VIIa administration to patients with Glanzmann's thrombasthenia: results of an international survey.
    Poon MC, D'Oiron R, Von Depka M, Khair K, Négrier C, Karafoulidou A, Huth-Kuehne A, Morfini M, International Data Collection on Recombinant Factor VIIa and Congenital Platelet Disorders Study Group.
    J Thromb Haemost; 2004 Jul; 2(7):1096-103. PubMed ID: 15219192
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Postpartum hemorrhage successfully treated with recombinant factor VIIa in Glanzmann thromboasthenia].
    Sugihara S, Katsutani S, Hyodo H, Hyodo M, Kudo Y, Fujii T, Kimura A.
    Rinsho Ketsueki; 2008 Jan; 49(1):46-50. PubMed ID: 18277596
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Clinical use of recombinant human activated factor VII (rFVIIa) in the prevention and treatment of bleeding episodes in patients with Glanzmann's thrombasthenia.
    Poon MC.
    Vasc Health Risk Manag; 2007 Jan; 3(5):655-64. PubMed ID: 18078017
    [Abstract] [Full Text] [Related]

  • 16. Weekly low-dose recombinant factor VIIa prophylaxis in Glanzmann thrombasthenia.
    Andiç N, Oğuz N, Gündüz E, Kiraz Bulduk T, Üsküdar Teke H.
    Blood Coagul Fibrinolysis; 2021 Jul 01; 32(5):349-351. PubMed ID: 33878047
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. New Insights Into the Treatment of Glanzmann Thrombasthenia.
    Poon MC, Di Minno G, d'Oiron R, Zotz R.
    Transfus Med Rev; 2016 Apr 01; 30(2):92-9. PubMed ID: 26968829
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.